Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs.

Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs.
复制标题

DOI:
10.1038/s41598-018-23482-4
复制
发表时间:
2018-03-26
期刊:
影响因子:
4.6
通讯作者:
Zhan CG
Zhan CG
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Ding K;Zhou Z;Hou S;Yuan Y;Zhou S;Zheng X;Chen J;Loftin C;Zheng F;Zhan CG

文献摘要

参考文献

被引文献

相似文献

人mPGES-1被认为是下一代抗炎药物的一个有前途的靶点,没有目前可用的抗炎药物的副作用,文献中已经报道了各种抑制剂。然而,所报道的人mPGES-1的有效抑制剂中没有一种显示也是小鼠或大鼠mPGES-1的有效抑制剂,这妨碍了将已建立的炎症相关疾病的小鼠/大鼠模型用于临床前研究。因此,尽管在设计和发现各种人mPGES-1抑制剂方面进行了大量努力,但mPGES-1作为下一代抗炎药物靶点的前景从未在使用mPGES-1抑制剂的任何野生型小鼠/大鼠模型中得到证实。在这里,我们报告发现一种新型的选择性mPGES-1抑制剂有效的人类和小鼠mPGES-1酶,通过基于结构的合理设计。基于使用野生型小鼠的体内研究,该先导化合物确实无毒,口服生物可利用,并且与目前可用的药物塞来昔布相比,在降低PGE 2(一种炎症标志物)水平方面更有效。这是首次在野生型小鼠中证明mPGES-1确实是下一代抗炎药物的有希望的靶点。
Human mPGES-1 is recognized as a promising target for next generation of anti-inflammatory drugs without the side effects of currently available anti-inflammatory drugs, and various inhibitors have been reported in the literature. However, none of the reported potent inhibitors of human mPGES-1 has shown to be also a potent inhibitor of mouse or rat mPGES-1, which prevents using the well-established mouse/rat models of inflammation-related diseases for preclinical studies. Hence, despite of extensive efforts to design and discover various human mPGES-1 inhibitors, the promise of mPGES-1 as a target for the next generation of anti-inflammatory drugs has never been demonstrated in any wild-type mouse/rat model using an mPGES-1 inhibitor. Here we report discovery of a novel type of selective mPGES-1 inhibitors potent for both human and mouse mPGES-1 enzymes through structure-based rational design. Based on in vivo studies using wild-type mice, the lead compound is indeed non-toxic, orally bioavailable, and more potent in decreasing the PGE2 (an inflammatory marker) levels compared to the currently available drug celecoxib. This is the first demonstration in wild-type mice that mPGES-1 is truly a promising target for the next generation of anti-inflammatory drugs.
DOI: 10.1016/j.bmcl.2009.08.085
发表时间: 2009-10-15
影响因子: 2.7
作者:
Giroux, Andre;Boulet, Louise;Friesen, Richard W.
通讯作者: Friesen, Richard W.
DOI: 10.1016/j.bcp.2009.11.011
发表时间: 2010-04-01
影响因子: 5.8
作者:
Bruno, Annalisa;Di Francesco, Luigia;Patrignani, Paola
通讯作者: Patrignani, Paola
DOI: 10.1021/jm200092b
发表时间: 2011-07-14
影响因子: 7.3
作者:
Hieke, Martina;Greiner, Christine;Werz, Oliver
通讯作者: Werz, Oliver
DOI: 10.1016/j.ejmech.2012.05.014
发表时间: 2012-08-01
影响因子: 6.7
作者:
Chini, Maria Giovanna;De Simone, Rosa;Bifulco, Giuseppe
通讯作者: Bifulco, Giuseppe
DOI: 10.1016/j.bmcl.2018.02.011
发表时间: 2018-03-01
影响因子: 2.7
作者:
Ding K;Zhou Z;Zhou S;Yuan Y;Kim K;Zhang T;Zheng X;Zheng F;Zhan CG
通讯作者: Zhan CG